2SATOH M, PARENT A D, ZHANG J H.Inhibitory effect with antisense mitogen-activated protein kinase oligodeoxynueleotide against cerebral vasospasm in rats [J]. Stroke, 2002, 33(3):775 -781.
3KUSAKA G, KIMURA H, KUSAKA I, et al. Contribution of Src tyrosine kinase to cerebral vasospasm after subaraehnoid hemorrhage [J]. J Neurosurg,2003,99(2):383 - 390.
4KASUYA H, ONDA H, TAKESHITA M, et al. Efficacy and safety of nicardipine prolonged-release implants for preventing vasospasm in humans [J]. Stroke, 2002, 33(4): 1011 - 1015.
5BIONDI A, RICCIARDI G K, PUYBASSETL. Intra-arterial nimodipine for the treatment of symptomatic cerebral vasospasm after aneurysmal subarachnoid hemorrhage: preliminary results [J] .AJNR Am J Neuroradiol, 2004,25 (6) : 1067 - 1076.
6KHURANA V G, SMITH L A, BAKER T A, et al. Protective vasomotor effects of in vivo recombinant endothelial nitric oxide synthase gene expression in a canine model of cerebral vasospasm [ J ]. Stroke, 2002,33(3): 782 -789.
7KATOH H, SHIMA K, SHIMIZU A, et al. Clinical evaluation of the effect of percutaneous transluminal angioplasty and intra-arterial papaverine infusion for the treatment of vasospasm following aneurysmal subarachnoid hemorrhage [J]. Neurol Res, 1999,21 (2): 195 -203.
8ONO S, KOMURO T, MACDONALD R L. Heme oxygenase- 1 gene therapy for prevention of vasospasm in rats [J] . J Neurosurg,2002,96(6): 1094 - 1102.
9TREGGIARI M M, ROMAND J A, MARTIN J B, et al. Cervical sympathetic block to reverse delayed ischemic neurological deficits after aneurysmal subarachnoid hemorrhage [J] . Stroke,2003,34 (4): 961 - 967.
10HANDA Y, WEIR B K, NOSKO M, et al. The effect of timing of clot removal on chronic vasopasm in a primate model [J]. J Neuresurg, 1987, 67(4): 558 - 564.
